WENDY SUBASIC: Open Payments
NPI 1427107580 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 9 payments from 8 companies in 2025. Trend: 2023 $752 · 2024 $717 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| IMMUNITYBIO, INC. | 1 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $86 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| 180 Medical, Inc. | 1 | $25 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Endo USA, Inc. | 1 | $18 |
Products named: ANKTIVA, Nubeqa, KEYTRUDA, PYLARIFY, PROVENGE, Disease Management Solutions Equipment Undivided, AVEED.
Industry payments across MD — which companies pay providers there.
